Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trial
AIMS-2-TRIALS-CT1：一项随机、双盲、安慰剂对照的II期临床试验，旨在评估阿巴氯芬在自闭症儿童和青少年中的疗效、安全性和耐受性。
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2026.103760
Parellada, M; San José Cáceres, A; Delorme, R; Moscoso, A; Moreno, C; Calvo, R; Canal-Bedia, R; Franco Martín, M A; Charman, T; Strydom, A; Parr, J R; Urbiola Merino, E; Burdeus-Olavarrieta, M; Hernández Jusdado, P; Solis, A; Lucas, M; Sipos, L; González Navarro, P; Blázquez, A; Lázaro, L; Tomás, A; Humeau, E; Antoun, S; Cooke, J; Megalogeni, M; Liang, H; de-Vena-Díez, V B; Leonard, H; White, N; Wang, P; Walton-Bowen, K; Winter-van Rossum, I; Murphy, D; Arango, C
